ARCHIVES

Commercial Labs Open Drive To Get More NIH Business, Including Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

Five Contracts Funded Under Unconventional Innovations Program

October 22, 1999

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013

OMB Orders NCI to Cut 12 Percent Until Final budget Is Approved; Grants Being Renegotiated

December 4, 1981

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

NCI blocked groups from phase III Iressa studies.

April 30, 2004